Clinical Trial of Sintilimab Combined With Gemcitabine/Carboplatin Regimen in the Treatment of Advanced Primary Pulmonary Lymphoepithelioma-like Carcinoma

Status:
Recruiting

Trial end date:
2022-08-01

Target enrollment:

Participant gender:

The trial was designed to explore the safety and efficacy of sintilimab combined with gemcitabine and carboplatin in the treatment of advanced LELC.

Phase 2

Zhou Chengzhi

Carboplatin
Gemcitabine